Header Logo
Last Name

Michelle Dianne Liedtke

InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPharmacy Clinical & Admin Sci
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Badowski ME, Walker S, Bacchus S, Bartlett S, Chan J, Cochran KA, Coon S, Liedtke M, Phillips BG, White T. Providing Comprehensive Medication Management in Telehealth. Pharmacotherapy. 2018 02; 38(2):e7-e16. PMID: 29239004.
      View in: PubMed
    2. Durham SH, Badowski ME, Liedtke MD, Rathbun RC, Pecora Fulco P. Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2017 May; 37(5):611-629. PMID: 28273373.
      View in: PubMed
    3. Masich A, Badowski ME, Liedtke MD, Fulco PP. Evaluation of the concurrent use of dolutegravir and metformin in human immunodeficiency virus-infected patients. Int J STD AIDS. 2017 10; 28(12):1229-1233. PMID: 28632474.
      View in: PubMed
    4. Liedtke MD, Tomlin CR, Skrepnek GH, Farmer KC, Johnson PN, Rathbun RC. HIV Pharmacist's Impact on Inpatient Antiretroviral Errors. HIV Med. 2016 11; 17(10):717-723. PMID: 27038405.
      View in: PubMed
    5. Miller MM, Liedtke MD, Lockhart SM, Rathbun RC. The role of dolutegravir in the management of HIV infection. Infect Drug Resist. 2015; 8:19-29. PMID: 25733917; PMCID: PMC4340460.
    6. Liedtke MD, Tomlin CR, Lockhart SM, Miller MM, Rathbun RC. Long-term efficacy and safety of raltegravir in the management of HIV infection. Infect Drug Resist. 2014; 7:73-84. PMID: 24672249; PMCID: PMC3965364.
    7. Kleyn TJ, Liedtke MD, Harrison DL, Lockhart SM, Salvaggio MR, Ripley TL, Rathbun RC. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic. Ann Pharmacother. 2014 Apr; 48(4):470-5. PMID: 24473489.
      View in: PubMed
    8. Rathbun RC, Lockhart SM, Miller MM, Liedtke MD. Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection. Ann Pharmacother. 2014 Mar; 48(3):395-403. PMID: 24259658.
      View in: PubMed
    9. Liedtke MD, Vanguri A, Rathbun RC. A probable interaction between warfarin and the antiretroviral TRIO study regimen. Ann Pharmacother. 2012 Nov; 46(11):e34. PMID: 23115227.
      View in: PubMed
    10. Rathbun RC, Liedtke MD. Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management. Pharmaceutics. 2011 Oct 21; 3(4):745-81. PMID: 24309307.
      View in: PubMed
    11. Liedtke MD, Rathbun RC. Drug interactions with antiretrovirals and warfarin. Expert Opin Drug Saf. 2010 Mar; 9(2):215-23. PMID: 20095918.
      View in: PubMed
    12. Rathbun CR, Liedtke MD, Blevins SM, Harrison D, Lockhart SM, Salvaggio M, Acosta EP. Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir. HIV Clin Trials. 2009 Sep-Oct; 10(5):328-36. PMID: 19906626.
      View in: PubMed
    13. Liedtke MD, Rathbun RC. Warfarin-antiretroviral interactions. Ann Pharmacother. 2009 Feb; 43(2):322-8. PMID: 19196837.
      View in: PubMed
    14. Liedtke MD, Lockhart SM, Rathbun RC. Anticonvulsant and antiretroviral interactions. Ann Pharmacother. 2004 Mar; 38(3):482-9. PMID: 14970370.
      View in: PubMed
    Liedtke's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description